Genzyme, a Sanofi company (NYSE: SNY), announced that the European Commission has granted marketing authorization for Aubagio® (teriflunomide) 14 mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE